Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18553/jmcp.2020.26.8.945 http://scihub22266oqcxt.onion/10.18553/jmcp.2020.26.8.945 32715960!10391236!32715960     free     free     free       J+Manag+Care+Spec+Pharm 2020 ; 26 (8): 945-947 Nephropedia Template TP {{tp|p=32715960|t=2020. COVID-19 and Drug Shortages: A Call to Action |pdf=|usr=}}{{32715960}} gab.com Text COVID-19 and Drug Shortages: A Call to Action JO: J Manag Care Spec Pharm http://www.kidney.de/pget.php?&tw=1&pmid=32715960 #FOAvip The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. DISCLOSURES: The authors declare no funding sources nor conflicts of interest. Twit Text FOAVip COVID-19 and Drug Shortages: A Call to Action ????J Manag Care Spec Pharm http://www.kidney.de/pget.php?&tw=1&pmid=32715960 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32715960 #FOAvip English Wikipedia <ref>{{Cite pmid|32715960}}</ref> COVID-19 and Drug Shortages: A Call to Action #MMPMID32715960 Shuman AG; Fox ER; Unguru Y J Manag Care Spec Pharm 2020[Aug]; 26 (8): 945-947 PMID32715960show ga The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. DISCLOSURES: The authors declare no funding sources nor conflicts of interest. |COVID-19[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Pharmaceutical Preparations/*supply & distribution[MESH] |Pharmacies/ethics/*statistics & numerical data[MESH] |Pharmacists[MESH] |Pharmacy Service, Hospital[MESH]COVID-19 and Drug Shortages: A Call to Action (epmc).pdf DeepDyve Pubget Overpricing